FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Selahattin Turen

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Extracellular Fluid

Concepts & Ideas

Physiology

Procedures

Co-author Network

Publications

TOP 3
Murat Sarisahin; Aysenur Cila; Enis Ozyar; Ferah Yıldız; Selahattin Turen
Prognostic significance of tumor volume in nasopharyngeal carcinoma.
Selahattin Turen; Enis Ozyar; Kadri Altundag; Ibrahim Gullu; I Lale Atahan
Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Kadri Altundag; Ozden Altundag; Serap Akyurek; Kamile Silay; Selahattin Turen
Angiotensin 1-7 and risk for breast cancer recurrence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Selahattin Turen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Murat Sarisahin; Aysenur Cila; Enis Ozyar; Ferah Yıldız; Selahattin Turen
Prognostic significance of tumor volume in nasopharyngeal carcinoma.
Auris, nasus, larynx 2011;38(2):250-4.
2007: Selahattin Turen; Enis Ozyar; Kadri Altundag; Ibrahim Gullu; I Lale Atahan
Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Cancer investigation 2007;25(5):315-21.
2006: Kadri Altundag; Ozden Altundag; Serap Akyurek; Kamile Silay; Selahattin Turen
Angiotensin 1-7 and risk for breast cancer recurrence.
Cancer chemotherapy and pharmacology 2006;58(2):283; author reply 284.
2006: Kadri Altundag; Ozden Altundag; Mustafa A Atik; Cem Boruban; Muzaffer B Altundag; Selahattin Turen
Recent findings for anti-metastatic potential of heparin.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(3):376-7.
2006: Kadri Altundag; Ozden Altundag; Serap Akyurek; Ebru Karakaya; Selahattin Turen
Inactivation of E-cadherin and less sensitivity of lobular breast carcinoma cells to chemotherapy.
Breast (Edinburgh, Scotland) 2006;15(3):300.
2006: Kadri Altundag; Ozden Altundag; Ozlem Gundeslioglu; Selahattin Turen; Rabiul Islam; Mustafa A Atik
Low incidence of mamographically detected microcalcification in breast cancer patients with lobular histology may be attributed to low levels of osteopontin.
Medical hypotheses 2006;67(2):421-2.
2006: Ozden Altundag; Kadri Altundag; Selahattin Turen; Esra Gunduz; Mustafa A Atik
Aromatase inhibitors may be effective in the management of advanced hepatocellular carcinoma.
Medical hypotheses 2006;66(6):1257.
2006: Kadri Altundag; Mevlut Kurt; Rabiul Islam; Ozden Altundag; Selahattin Turen
Incidence of plasma cell dyscrasia as a second primary malignancy may be low in postmenopausal breast cancer survivors treated with selective estrogen receptor modulator or aromatase inhibitor.
Medical hypotheses 2006;66(2):444-5.
2006: Kadri Altundag; Ozden Altundag; Cem Boruban; Muzaffer B Altundag; Selahattin Turen
Weekly paclitaxel may improve locoregional recurrence by decreasing interstitial fluid pressure in operable node-positive breast cancer patients.
Medical hypotheses 2006;66(1):211-2.
2005: Kadri Altundag; Ozden Altundag; Mauricio Z Baptista; Selahattin Turen; Mustafa A Atik
Re: Cetuximab therapy and symptomatic hypomagnesemia.
Journal of the National Cancer Institute 2005;97(23):1791-2.
2005: Kadri Altundag; Ozden Altundag; Mauricio Z Baptista; Selahattin Turen; Mustafa A Atik
Is there an association between high heparanase level and osteoporosis risk in breast cancer patients without clinical evidence of bone metastases?
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(12):2195-6.
2005: Ozden Altundag; Kadri Altundag; Cem Boruban; YAVUZ SILAY; Selahattin Turen
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a Phase II clinical trial.
Cancer 2005;104(9):2033-4; author reply 2034.
2005: Rabiul Islam; Kadri Altundag; Mevlut Kurt; Ozden Altundag; Selahattin Turen
Association between obesity and multiple myeloma in postmenopausal women may be attributed to increased aromatization of androgen in adipose tissue.
Medical hypotheses 2005;65(5):1001-2.
2005: Mevlut Kurt; Kadri Altundag; Ozden Altundag; Selahattin Turen
Tamoxifen may increase insulin requirement in breast cancer patients with type 1 diabetes mellitus through its agonistic activity on splenic endothelial cells and inhibitory effect on pancreatic beta cells.
Medical hypotheses 2005;65(4):815-6.
2005: Ozden Altundag; Kadri Altundag; Kamile Silay; Selahattin Turen
Gender differences in the dihydropyrimidine dehydrogenase expression may contribute to higher toxicity in women treated with 5-fluorouracil therapy.
Medical hypotheses 2005;65(6):1196.
2005: Ozden Altundag; Kadri Altundag; Cem Boruban; Muzaffer B Altundag; Selahattin Turen
Phenytoin may increase the efficacy of temozolomide by methylating DNA-repair enzyme, O6-methylguanine-DNA methyltransferase in patients with glioblastoma.
Medical hypotheses 2005;65(4):819-20.
2005: Kadri Altundag; Ozden Altundag; Selahattin Turen
Does paclitaxel decrease the interstitial fluid pressure and improve oxygenation in breast cancer in a schedule-dependent fashion?
Medical hypotheses 2005;65(5):1002-3.